Latest News On Biden Administration

Latest California Healthline Stories

KFF Health News' 'What the Health?': The State of the Union Is … Busy

At last, Congress is getting half of its annual spending bills across the finish line, albeit five months after the start of the fiscal year. Meanwhile, President Joe Biden delivers his annual State of the Union address, an over-the-counter birth control pill is (finally) available, and controversy erupts over new public health guidelines for covid-19 isolation. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Neera Tanden, the White House domestic policy adviser, about Biden’s health agenda. Plus, for “extra credit,” the panelists suggest health policy stories they read this week that they think you should read, too.

Biden Is Right. The US Generally Pays Double That of Other Countries for Rx Drugs.

Research has consistently found that, overall, U.S. prescription drug prices are significantly higher, sometimes two to four times as high, compared with prices in other high-income industrialized countries. However, some market factors can obscure actual prices, making comparisons harder.

Biden’s Got a Taker for One of His Gun Safety Proposals: California

California could give President Biden a political win this year on gun violence. State senators passed sweeping legislation in January that would toughen gun storage requirements, embracing a White House priority that has languished in Congress. Many states, including California, have laws in place requiring gun owners to securely store their firearms when children are […]

California Takes Up White House Call to Toughen Gun Storage Rules

State lawmakers are weighing legislation that would require gun owners to keep their firearms locked up most of the time, a move advocated by the Biden administration.

KFF Health News' 'What the Health?': Alabama Court Rules Embryos Are Children. What Now?

In a first-of-its-kind ruling, the Alabama Supreme Court has determined that embryos created for in vitro fertilization procedures are legally people. The decision has touched off massive confusion about potential ramifications, and the University of Alabama-Birmingham has paused its IVF program. Meanwhile, former President Donald Trump is reportedly planning to endorse a national 16-week abortion ban, while his former administration officials are planning further reproductive health restrictions for a possible second term. Lauren Weber of The Washington Post, Rachana Pradhan of KFF Health News, and Victoria Knight of Axios join KFF Health News’ Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week that they think you should read, too.

Southern Lawmakers Rethink Long-Standing Opposition to Medicaid Expansion

While many Republican state lawmakers remain firmly against Medicaid expansion, some key leaders in holdout states are showing a willingness to reconsider. Public opinion, financial incentives, and widening health care needs make resistance harder.

KFF Health News' 'What the Health?': Biden Wins Early Court Test for Medicare Drug Negotiations

A federal district court judge dismissed a lawsuit attempting to invalidate the Biden administration’s Medicare prescription-drug price negotiation program. But the suit turned on a technicality, and several more court challenges are in the pipeline. Meanwhile, health policy pops up in Super Bowl ads, as Congress approaches yet another funding deadline. Alice Miranda Ollstein of Politico, Lauren Weber of The Washington Post, and Rachel Cohrs of Stat join KFF Health News’ Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.

States Target Health Insurers’ ‘Prior Authorization’ Red Tape

Doctors, patients, and hospitals have railed for years about the prior authorization processes that health insurers use to decide whether they’ll pay for patients’ drugs or medical procedures. The Biden administration announced a crackdown in January, but some state lawmakers are looking to go further.